Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery

Withdrawn before enrolling · Phase 4

Conditions studied: Orthognathic Surgery

In brief

This research is being done to determine quantitative and qualitative differences in patients' post-operative pain levels following elective orthognathic surgery after the local administration of a liposomal bupivacaine injection. A primary objective is to determine whether using a liposomal bupivacaine injection placed locally at the conclusion of elective orthognathic surgery will decrease pain levels (as determined by VAS scores). A secondary objective is to examine whether using a long acting liposomal bupivacaine injection locally at the conclusion of elective orthognathic surgery leads to decreased use of narcotics post-operatively.

Key facts

Study ID

NCT03318757

Run by

Boston University

People needed

0

Starts

2020-09-01

Expected to finish

2021-12-01

Last updated by the study team

2020-06-11

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• males and females 18-40 years of age undergoing elective double jaw orthognathic surgery

You may not qualify if…

• pregnancy
• known hypersensitivity to any local anesthetic

Where it is running

• Boston Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.